In lung cancer, most of the mutations of EGFR are caused by the rearrangement and amplification of the EGFR gene or the selective splicing of mRNA (Cheng et al., 2012; Cheng and Eble, 2013). This evidence concerns the gene EGFR and lung carcinoma.